Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)
Short-Term Debt
$400.70M
Quarterly · Period ending: · USD

BIO Short-Term Debt
Latest reported$400.70Mperiod ending
Latest reported$400.70Mperiod ending
BIO Quarterly Short-Term Debt ($8.60M → $400.70M)
Quarterly short-term debt
High-resolution chart · PNG
BIO short-term debt history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Short-Term Debt (USD) |
|---|---|
| 17,334,000 | |
| 17,992,000 | |
| 18,146,000 | |
| 13,786,000 | |
| 19,564,000 | |
| 13,805,000 | |
| 22,000,000 | |
| 9,700,000 | |
| 7,000,000 | |
| 5,900,000 | |
| 9,400,000 | |
| 10,000,000 | |
| 10,400,000 | |
| 11,700,000 | |
| 10,800,000 | |
| 4,500,000 | |
| 6,600,000 | |
| 11,900,000 | |
| 5,600,000 | |
| 11,800,000 | |
| 10,300,000 | |
| 10,100,000 | |
| 14,300,000 | |
| 14,300,000 | |
| 20,100,000 | |
| 22,600,000 | |
| 21,600,000 | |
| 24,100,000 | |
| 22,400,000 | |
| 25,600,000 | |
| 30,800,000 | |
| 65,800,000 | |
| 68,800,000 | |
| 34,300,000 | |
| 36,400,000 | |
| 39,000,000 | |
| 53,500,000 | |
| 32,000,000 | |
| 31,700,000 | |
| 33,600,000 | |
| 32,100,000 | |
| 31,400,000 | |
| 28,200,000 | |
| 23,200,000 | |
| 27,800,000 | |
| 23,700,000 | |
| 25,500,000 | |
| 21,700,000 | |
| 19,300,000 | |
| 16,400,000 | |
| 18,700,000 | |
| 10,600,000 | |
| 8,600,000 |